Rassiah-Szegedi Premavathy, Salter Bill J, Fuller Clifton D, Blough Melissa, Papanikolaou Niko, Fuss Martin
Cancer Therapy & Research Center, San Antonio, Texas, USA.
Acta Oncol. 2006;45(7):989-94. doi: 10.1080/02841860600919225.
To compare finite-size pencil beam/equivalent path-length (FSPB/EPL) and Monte Carlo (MC) SBRT dose computations for serial tomotherapy and to quantitatively assess dose differences between the dose calculation methods. Based on 72 SBRT plans for pulmonary targets, FSPB/EPL, considering the inhomogeneous lung environment, and MC calculations were performed to establish differences between FSPB/EPL predicted dose and MC derived doses. Compared with MC, FSPB/EPL consistently overestimated minimum doses to the clinical target volume and planning target volumes by an average of 18.1+/-7.15% (range 4 to 33.4%), and 21.9+/-10.4% (range 1.2 to 45.5%), respectively. The respective mean target dose differences were 15.5+/-7.4% (2.8-36.4%) and 19.2+/-7.6% (3.6-40.1%). Deviations from MC doses were lesion size and location dependent, with smaller lesions completely embedded into lung parenchyma being most susceptible. Larger lesion in contact with mediastinum and chest wall showed lesser differences. In comparison with MC dose calculation, FSPB/EPL overestimates doses delivered to pulmonary SBRT targets. The observed dose differences may have impact on local tumor control rates, and may deserve consideration when using fast, but less accurate dose calculation methods.
比较串行断层放疗中有限尺寸铅笔束/等效路径长度(FSPB/EPL)和蒙特卡罗(MC)立体定向体部放疗(SBRT)剂量计算,并定量评估剂量计算方法之间的剂量差异。基于72个肺部靶区的SBRT计划,考虑到不均匀的肺部环境,进行了FSPB/EPL和MC计算,以确定FSPB/EPL预测剂量与MC导出剂量之间的差异。与MC相比,FSPB/EPL始终高估临床靶区和计划靶区的最小剂量,平均分别高估18.1±7.15%(范围4%至33.4%)和21.9±10.4%(范围1.2%至45.5%)。各自的平均靶区剂量差异分别为15.5±7.4%(2.8%至36.4%)和19.2±7.6%(3.6%至40.1%)。与MC剂量的偏差取决于病变大小和位置,完全嵌入肺实质的较小病变最易受影响。与纵隔和胸壁接触的较大病变显示出较小的差异。与MC剂量计算相比,FSPB/EPL高估了肺部SBRT靶区的剂量。观察到的剂量差异可能会影响局部肿瘤控制率,在使用快速但不太准确的剂量计算方法时可能值得考虑。